oral hmas in mds management: adherence and accessibility
Published 4 years ago • 26 plays • Length 4:49Download video MP4
Download video MP3
Similar videos
-
6:16
oral hmas in mds: personal experience and future directions
-
3:08
mds management: use of transfusion alongside hmas
-
5:18
mds management: ascertain equivalence study
-
4:48
hypomethylating agents in mds management
-
9:41
the i4mds consortium and immune monitoring in mds
-
58:22
myelodysplastic syndromes: key take-home messages from eha and asco 2024
-
24:57
dr sharona dayan on vitamin d mirobiome and oral health
-
3:54
life with mds: jill shares how her family helped her overcome an mds diagnosis
-
6:21
wisdm: how digital medicine personalises and optimises healthcare
-
2:02
what are hypomethylating agents and when are they used for mds?
-
1:37
amirali masoumi, md
-
1:03
exploring the safety & efficacy of magrolimab plus oral decitabine/cedazuridine in mds
-
2:23
benefits, applicability & uses of the ipss-m in mds
-
1:22
key advances in mds management
-
0:45
spectrum of numed: proximity
-
52:33
msa behandling (treatment of msa) - anne-mette hejl, md
-
0:19
hcp medulla oblangata dwi oct
-
0:44
mds: an update on pevonedistat plus azacitidine
-
4:42
mashiat mimosa: optimisation of a method for potential molecular testing of cns tumours
-
0:18
what is the best anaesthesia choice? - md codes
-
1:54
mds as an immunoresponsive disease
-
1:50
hypomethylating agent based combinations in mds